Literature DB >> 6544358

Uptake of adriamycin by human leukemic cells as measured by flow cytometry.

H D Preisler, A Raza.   

Abstract

Leukemic cells were obtained from 12 patients with acute nonlymphocytic leukemia and 2 patients with acute lymphocytic leukemia. The specimens were incubated with a range of concentrations of adriamycin (Adr) for different periods of time and then analyzed by flow cytometry. For incubations of up to 5 h, only cells exposed to 5 or more micrograms of Adr ml-1 became fluorescent while cells incubated with 1 microgram ml-1 for 24 h became fluorescent. Fluorescence decreased when the cells were washed and further decreased when the cells were incubated in Adr-free media. The cells from different patients exhibited a wide range of Adr uptakes and retentions. Simultaneous analysis of right angle light scatter and fluorescence intensity demonstrated that there may be subpopulations of cells whose Adr uptake and/or retention differ from the weighted mean population values. With this method rare cells which fail to take up Adr can be recognized.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6544358     DOI: 10.1007/bf02935324

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  17 in total

1.  Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.

Authors:  J W Yates; H J Wallace; R R Ellison; J F Holland
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

2.  Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response.

Authors:  D Kessel; V Botterill; I Wodinsky
Journal:  Cancer Res       Date:  1968-05       Impact factor: 12.701

3.  Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy.

Authors:  Y M Rustum; H D Preisler
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

4.  Concentration of hemopoietic stem cells using a light-activated cell sorter.

Authors:  G van den Engh; J Visser; S Bol; B Trask
Journal:  Blood Cells       Date:  1980

5.  Differences in uptake of adriamycin and daunomycin by normal BM cells and acute leukemia cell determined by flow cytometry.

Authors:  P Sonneveld; G J van den Engh
Journal:  Leuk Res       Date:  1981       Impact factor: 3.156

6.  Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo.

Authors:  D W Yesair; P S Thayer; S McNitt; K Teague
Journal:  Eur J Cancer       Date:  1980-07       Impact factor: 9.162

7.  Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.

Authors:  P M Kanter; H S Schwartz
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

8.  Combination chemotherapy for acute lymphoblastic leukaemia in adults.

Authors:  T A Lister; J M Whitehouse; M E Beard; R L Brearley; P F Wrigley; R T Oliver; J E Freeman; R K Woodruff; J S Malpas; A M Paxton; D Crowther
Journal:  Br Med J       Date:  1978-01-28

9.  Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.

Authors:  D S Chervinsky; J J Wang
Journal:  J Med       Date:  1976

10.  Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.

Authors:  J K Rees; R M Sandler; J Challener; F G Hayhoe
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

View more
  3 in total

1.  Potential limitations of in vitro clonogenic drug sensitivity assays.

Authors:  G W Dong; H D Preisler; R Priore
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis.

Authors:  Xue Wang; Songbing He; Yuting Gu; Qiwei Wang; Xiao Chu; Min Jin; Liang Xu; Qiong Wu; Qianjun Zhou; Bei Wang; Yanyun Zhang; Hui Wang; Leizhen Zheng
Journal:  EBioMedicine       Date:  2019-02-06       Impact factor: 8.143

3.  Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM).

Authors:  R Raijmakers; P Speth; T de Witte; P Linssen; J Wessels; C Haanen
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.